Medijski sadržaj
- Tweetovi
- Tweetovi i odgovori
- Medijski sadržaj, trenutna stranica.
-
#Precigen completes series of transactions to solidify healthcare focus. Name changes to@Precigen from@Intrexon and ticker symbol to@Nasdaq:$PGEN#Maryland#biopharma#GeneTherapy#CellTherapy#Immunotherapy https://prn.to/2SbVCiI pic.twitter.com/WAtE8eUz2H
-
Triple-Gene to highlight its investigational
#genetherapy in Phase 1 for treatment of#heartfailure at#BiotechShowcase TODAY January 15th at 11:30am PT in Franciscan B at the Hilton San Francisco Union Square$XON#Precigen#cardiovasculardisease#JPMHC20#JPM2020#JPMorgan2020pic.twitter.com/QkvSDJXSYy
-
At
#JPMHC20? Listen to Dr. Helen Sabzevari, President & CEO of@Precigen, at 5pm PT in California West present on#Precigen progress and 2020 look ahead OR watch live webcast here: http://ow.ly/2ndc50xVC11$XON#JPM2020#JPMorgan2020#GeneTherapy#CellTherapy#Immunotherapypic.twitter.com/7R0AOpVECr
-
Triple-Gene to highlight advantages of its multigenic approach for treatment of
#heartfailure at#BiotechShowcase on January 15th, 2020 at 11:30AM PT at the Hilton San Francisco Union Square. Read more here: http://ow.ly/Aof250xR5IF#cardiovasculardisease#genetherapy$XONpic.twitter.com/ftEX8ZHm1s
-
Intrexon subsidiary Triple-Gene announces completion of dosing in Phase 1 trial of INXN-4001, first multigenic investigational
#genetherapy candidate for treatment of#heartfailure. Learn more here: http://ow.ly/rDyV50x4Cwt$XON#cardiovasculardiseasepic.twitter.com/gbN9EbxT8V
-
$XON to Announce Third Quarter Financial Results on Nov 12th.@Precigen to host conference call that day at 11am ET to provide Precigen business and pipeline updates. To learn more and register, click here: http://ow.ly/Lw4750x1N4Q#immunotherapy#genetherapy#celltherapypic.twitter.com/q32MzSmuXQ
-
At
#BIOInvestorForum? Don’t miss#ActoBio Therapeutics™ CEO Pieter Rottiers presenting an overview of the innovative ActoBiotics® platform today Wednesday October 23 @ 9:15 AM PT. Read more: http://actobio.com or follow us on LinkedIn or Twitter@ActobioT#bif19#biotechpic.twitter.com/KF8zE57d8A
-
At
#SynBioBeta? Don't miss#ActoBio Therapeutics™ CEO Pieter Rottiers' presentation at 4PM today about the innovative ActoBiotics® platform. More: http://www.actobio.com or follow on Twitter@ActobioT or LinkedIn.#actobiotics#healthcare#biotechpic.twitter.com/CuLsXpxme1
-
David Witte formerly of
@IHSMarkit to lead MBP Titan LLC, standalone subsidiary company of Intrexon comprising Intrexon’s#Methane#Bioconversion Platform. Discover more: http://ow.ly/3ewV50wrZUP .$XON#energy#bioengineering#betterDNApic.twitter.com/tohCCG1k9Q
-
Thrilled to be invited to kickoff the
@Bio_Markets first annual#SynBioMarkets19 conference. For more details, click here: https://bit.ly/2WPwy69 Hope to see you there.$XONpic.twitter.com/L60Wqa9Jdg
-
Breaking:
@ActobioT Receives IND Green Light for New Antigen-Specific#Immunotherapy Study Aimed at Improving Celiac Patients' Tolerance of#Gluten.#CeliacDisease is an under-served market with 0 approved pharmacological therapies. Discover more: https://bit.ly/2L7uIVJ$XON -pic.twitter.com/KLzCbnFR61
-
Breaking News:
$XON@Precigen Announces First Patient Dosed in Phase 1 Study of PRGN-3005#UltraCAR-T in Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal#Cancer. Discover more: https://bit.ly/2MAJuXj#SolidTumorpic.twitter.com/JwTZ4KaloN
-
Mark your calendar:
$XON to Announce Second Quarter and First Half 2019 Financial Results on Aug 8th. Conference call to be held that day at 5:30 PM ET to discuss the results and provide a general business update. To learn more and register, click here: http://ow.ly/Eam450vjWnb pic.twitter.com/bzoyHcL2Ia
-
@Oxitec highlighted in the latest@NakedScientists podcast reaching 3M+ listeners on the heels of being honored by@MalariaNoMore for its work in using biotechnology to turn mosquitoes into allies in the fight against malaria. Listen now and share: https://bit.ly/2XcIYFt$XONpic.twitter.com/psH5JZUoXJ
-
Breaking News: Intrexon ($XON) and Surterra Wellness Partner in $100mm Deal to Advance Commercial Scale Fermentation-based
#Cannabinoid Production. Discover more: https://bit.ly/2ZxgSBc . Please share/RT@IAmBiotech@SynBioBeta@Hightimesmag#cannabis#marijuana#cbd#thcpic.twitter.com/9ys3qWUeI6
-
@Precigen President Helen Sabzevari explains “we reduced the manufacturing to overnight” during#BIO2019 Immuno-oncology: Taking#Immunotherapies to the Next Level panel.#EndCancer@IAmBiotech$XON#standingroomonlypic.twitter.com/kSsIyvmQq7
-
Reminder: Helen Sabzevari, PhD, President of
@Precigen, will participate in the panel "Immuno-Oncology: Taking#Immunotherapies to the Next Level" on June 6th from 10:30 am-12:00 pm ET. Over 250+ people pre-registered so make sure you come early!#BIO2019#standingroomonly$XONpic.twitter.com/AucqtD5IDz – mjesto: Pennsylvania Convention Center
-
Packed house learning about
$XON - if you are at#BIO2019 - come see us at booth 1313. We have a gift waiting for you, and it’s not just knowledge!pic.twitter.com/qHQ4q1jeDn – mjesto: Pennsylvania Convention Center
-
On the heels of announcements made this morning, exciting to hear RJ Kirk articulate Intrexon’s One Health mission. A lot of excitement in the air.
$XON#BIO2019pic.twitter.com/uz2aahGAOM – mjesto: Pennsylvania Convention Center
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.